MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to common...
-$11,837K
Interest income, net
$1,390K
(68.89%↑ Y/Y)
Foreign currency
transaction loss (gain)
$131K
(144.56%↑ Y/Y)
Other income
(expense), net
$19K
(147.50%↑ Y/Y)
Net loss
-$11,837K
(-60.89%↓ Y/Y)
Total other income,
net
$1,540K
(22.91%↑ Y/Y)
Loss from operations
-$13,377K
(-55.37%↓ Y/Y)
Total operating
expenses
$13,377K
(55.37%↑ Y/Y)
General and
administrative
$7,543K
(113.20%↑ Y/Y)
Research and development
$5,834K
(15.02%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Benitec Biopharma Inc. (BNTC)
Benitec Biopharma Inc. (BNTC)